Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact

NCT01753349 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT01753349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01753349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International Observational Prospective Study On Long-Term Response To Botulinum Toxin Type A (BoNT-A) Injections In Subjects Suffering From Idiopathic Cervical Dystonia (CD) - Pharmaco-Economic Impact
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
September 25, 2017
Enrollment
1,050 (actual)
Sites
113

Conditions

As the registry lists them; a condition with its own page is linked.

cervical dystonia